Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients

被引：0
|
作者：
M Ruhnke
J Paiva
W Meersseman
J Pachl
I Grigoras
G Sganga
F Menichetti
P Montravers
G Auzinger
G Dimopoulos
M Borges Sá
P Miller
T Marček
M Kantecki
机构：
[1] Charité University Hospital,
[2] Hospital São João,undefined
[3] University Hospital Leuven,undefined
[4] University Hospital Královské Vinohrady,undefined
[5] University Hospital Sf Spiridon,undefined
[6] University Hospital A Gemelli,undefined
[7] University Hospital Pisa,undefined
[8] Hospital Bichat Claude Bernard,undefined
[9] King's College Hospital,undefined
[10] University Hospital Attikon,undefined
[11] Hospital Son Llatzer,undefined
[12] Pfizer,undefined
[13] Pfizer,undefined
来源：
Critical Care | / 15卷 / Suppl 1期
关键词：
Candidiasis; Azole; Global Response; Anidulafungin; Sofa Score;
D O I：
10.1186/cc9660
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study
    Hasan, Md Jahidul
    Neelotpol, Sharmind
    Rabbani, Raihan
    JOURNAL OF CRITICAL CARE MEDICINE, 2022, 8 (02) : 89 - 99
  • [42] Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
    Grau, S.
    Pozo, J. C.
    Roma, E.
    Salavert, M.
    Barrueta, J. A.
    Peral, C.
    Rodriguez, I.
    Rubio-Rodrguez, D.
    Rubio-Terres, C.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 527 - 535
  • [43] Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
    Georg Auzinger
    E. Geoffrey Playford
    Christopher N. Graham
    Hediyyih N. Knox
    David Weinstein
    Michal Kantecki
    Haran Schlamm
    Claudie Charbonneau
    BMC Infectious Diseases, 15
  • [44] An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America
    Nucci, Marcio
    Colombo, Arnaldo L.
    Petti, Marco
    Magana, Martin
    Abreu, Paula
    Schlamm, Haran T.
    Sanchez, Sonia P.
    MYCOSES, 2014, 57 (01) : 12 - 18
  • [45] Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
    Auzinger, Georg
    Playford, E. Geoffrey
    Graham, Christopher N.
    Knox, Hediyyih N.
    Weinstein, David
    Kantecki, Michal
    Schlamm, Haran
    Charbonneau, Claudie
    BMC INFECTIOUS DISEASES, 2015, 15
  • [46] Invasive candidiasis in the ICU: Prophylaxis versus preemptive treatment
    Rotstein C.
    Current Infectious Disease Reports, 2008, 10 (6) : 454 - 458
  • [47] Invasive candidiasis in the ICU: evidence based and on the edge of evidence
    Hollenbach, Eike
    MYCOSES, 2008, 51 : 25 - 45
  • [48] High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: Epidemiology and antifungal susceptibility
    Dizbay, Murat
    Fidan, Isil
    Kalkanci, Ayse
    Sari, Nuran
    Yalcin, Burce
    Kustimur, Semra
    Arman, Dilek
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (02) : 114 - 120
  • [49] Invasive candidiasis in patients with implants
    Shoham S.
    Current Fungal Infection Reports, 2011, 5 (1) : 12 - 17
  • [50] Invasive yeast infections in neutropenic patients
    Ruiz Camps, Isabel
    Jarque, Isidro
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2016, 33 (03): : 170 - 175
12345